SCARLATA, GIUSEPPE GUIDO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 656
AS - Asia 650
EU - Europa 270
SA - Sud America 217
AF - Africa 31
Totale 1.824
Nazione #
US - Stati Uniti d'America 635
SG - Singapore 262
BR - Brasile 166
VN - Vietnam 128
CN - Cina 119
IT - Italia 115
IN - India 55
DE - Germania 48
HK - Hong Kong 20
NL - Olanda 20
RU - Federazione Russa 19
FI - Finlandia 16
AR - Argentina 15
EC - Ecuador 14
GB - Regno Unito 14
MX - Messico 12
ID - Indonesia 11
ZA - Sudafrica 10
AT - Austria 9
BD - Bangladesh 9
FR - Francia 8
IQ - Iraq 7
SE - Svezia 7
CA - Canada 5
PE - Perù 5
PK - Pakistan 5
PY - Paraguay 5
TR - Turchia 5
CL - Cile 4
IL - Israele 4
MA - Marocco 4
BG - Bulgaria 3
CO - Colombia 3
DZ - Algeria 3
JP - Giappone 3
KE - Kenya 3
PH - Filippine 3
UZ - Uzbekistan 3
VE - Venezuela 3
AZ - Azerbaigian 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
JO - Giordania 2
NG - Nigeria 2
SN - Senegal 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
ES - Italia 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
IR - Iran 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UA - Ucraina 1
ZM - Zambia 1
Totale 1.824
Città #
Dallas 195
San Jose 174
Singapore 102
Ashburn 74
Ho Chi Minh City 48
Santa Clara 47
Bengaluru 39
Hefei 38
Munich 30
Hanoi 26
Beijing 24
São Paulo 24
Hong Kong 20
Chicago 14
Turku 11
Milan 8
Catania 7
London 7
New York 7
Rio de Janeiro 7
Belo Horizonte 6
Florence 6
Kiel 6
Los Angeles 6
San Nicola Manfredi 6
St Louis 6
Amsterdam 5
Bari 5
Brasília 5
Hangzhou 5
Helsinki 5
Porto Alegre 5
Rome 5
Stockholm 5
Thái Bình 5
Vienna 5
Assago 4
Biên Hòa 4
Chennai 4
Da Nang 4
Guayaquil 4
Haiphong 4
Johannesburg 4
Nuremberg 4
Palermo 4
Potenza 4
San Francisco 4
Baghdad 3
Boardman 3
Boydton 3
Brooklyn 3
Campinas 3
Cosenza 3
Curitiba 3
Dhaka 3
Elk Grove Village 3
Lima 3
Lấp Vò 3
Manassas 3
Mexico City 3
Moscow 3
Mumbai 3
Santiago 3
Santo André 3
Shanghai 3
St Petersburg 3
Taranto 3
Tashkent 3
Tokyo 3
Turin 3
Addis Ababa 2
Ankara 2
Asunción 2
Atlanta 2
Avellaneda 2
Bagnara Calabra 2
Baku 2
Bauru 2
Blumenau 2
Bogotá 2
Boston 2
Campo Grande 2
Cao Lanh 2
Caxias do Sul 2
Council Bluffs 2
Criciúma 2
Dakar 2
Fermo 2
Gatchina 2
Guarulhos 2
Ha Long 2
Hacienda Ibarra 2
Honolulu 2
Hortolândia 2
Ibarra 2
Lagos 2
Manchester 2
Marrakesh 2
Montreal 2
Nairobi 2
Totale 1.161
Nome #
Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation 191
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 92
Are SARS-CoV-2 rapid antigen tests useful for the control of latest variants spreading? 66
The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review 66
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 61
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 61
Gastrointestinal symptoms, dietary regimen and anxiety levels during the COVID-19 pandemic among medical students: results from a web-based survey 55
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 52
The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review 50
Portal hypertension-associated gastric pathology: role of endoscopic banding ligation 47
Gut microbiota: the pathogenetic bridge between inflammatory bowel disease and metabolic-associated steatotic liver disease 43
Preventive and Therapeutic Effects of Baicalein, Galangin, and Isorhamnetin in Chronic Liver Diseases: A Narrative Review 43
The levels of inflammatory, angiogenic, and stress biomarkers in plasma of donors depending on anti-SARS-CoV-2 IgG titers 43
Clostridioides difficile Infection: Use of Inflammatory Biomarkers and Hemogram-Derived Ratios to Predict Mortality Risk in Hospitalized Patients 42
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease 42
Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience 41
Orthopedic Device-Related Infections Due to Emerging Pathogens Diagnosed by a Combination of Microbiological Approaches: Case Series and Literature Review 41
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 41
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 40
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 38
Prevalence of Colonization with Multidrug-Resistant Bacteria: Results of a 5-Year Active Surveillance in Patients Attending a Teaching Hospital 38
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 38
Comment on Meneghini et al. The Impact of Nutritional Therapy in the Management of Overweight/Obese PCOS Patient Candidates for IVF. Nutrients 2023, 15, 4444 37
Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma 37
Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review 36
Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition 35
Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study 35
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 35
Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series 33
Is the Mediterranean diet a good preventive measure for NASH? 33
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 31
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease 30
Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection 29
The Role of Cytokines in the Pathogenesis and Treatment of Alcoholic Liver Disease 28
The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation 27
Therapeutic success in primary biliary cholangitis and gut microbiota: a safe highway? 25
Should Routine Diagnostics Implement Gut Microbiota Analysis? 25
Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors 24
Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects 19
Post-Coronavirus Disease 2019 Pandemic Antimicrobial Resistance 19
Gender, Age, Alpha-fetoprotein, and Des-gamma-carboxyprothrombin Score as a Novel Approach to Early Detection of Hepatocellular Carcinoma: A Narrative Review 18
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features 15
Comment on Rotaru et al. Lean MASLD and IBD: Exploring the Intersection of Metabolic Dysfunction and the Gut–Liver Axis. Life 2025, 15, 288 14
Apolipoproteins Levels in Fatty Liver Disease: A Systematic Review and Meta-analysis 14
Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis 14
Annurca Apple Extract and Colorectal Cancer Prevention: Preliminary In Silico Evaluation of Chlorogenic Acid 11
Gut microbiota: origin or panacea for all ills? Gut microbiota and systemic diseases 11
The Mediterranean diet: historical benefits and contemporary challenges in Southern Italy 10
Metabolic Dysfunction-Associated Steatotic Liver Disease in a Patient with Phelan–McDermid Syndrome 9
Irritable bowel syndrome after Clostridioides difficile infection 7
The role of gut microbiota in the pathogenesis of primary biliary cholangitis: an immunological perspective 6
Totale 1.898
Categoria #
all - tutte 10.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202311 0 0 0 0 0 0 8 0 0 1 0 2
2023/202476 12 3 7 7 3 5 6 10 5 0 4 14
2024/2025415 28 7 23 14 43 64 16 20 17 7 67 109
2025/20261.396 61 192 249 196 128 86 174 71 160 79 0 0
Totale 1.898